<![CDATA[
Adistem Ltd began a clinical trial at the end of 2009 into the safety/efficacy of delivering autologous adipose-derived stem cells into the fibrotic lungs of ill patients, can now report very promising results.
Amsterdam, Netherlands, (PRWEB) September 26, 2011
Annual Congress of the European Respiratory Society. 25 September, 2011
According to the latest WHO estimates (2007), about 1 billion people in the world currently have chronic respiratory diseases. Respiratory diseases rank second in Europe in terms of mortality, incidence, prevalence and costs, with an estimated yearly financial burden of €100 billion due to health care costs and lost working days.
Professor Nikos Siafakas, President of the European Respiratory Society, points out: “We need to promote excellence in European respiratory research to improve the quality of life of millions of European citizens suffering from lung diseases by strategic investment in and commitment to competitively driven medical research.”
Ref and Read more: http://www.sfgate.com/cgi-bin/article.cgi?f=/g/a/2011/09/26/prweb8815568.DTL
]]>